Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Pommier

Showing results (11-20 of 624) with videos related to

Pageof 63
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Targeting Topoisomerase I in the Era of Precision MedicineAnish Thomas, Yves Pommier
Science Translational Medicine|July 8, 2016
Small cell lung cancer: Time to revisit DNA-damaging chemotherapyAnish Thomas, Yves Pommier
Biochemistry|October 2, 2008
Mitochondrial topoisomerase I sites in the regulatory D-loop region of mitochondrial DNAHongliang Zhang, Yves Pommier
Cancer Research|April 14, 2023
BRCAness, Homologous Recombination Deficiencies, and Synthetic LethalityJunko Murai, Yves Pommier
Trends in Pharmacological Sciences|March 8, 2005
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discoveryYves Pommier, Jacqueline Cherfils
Current Medicinal Chemistry. Anti-Cancer Agents|August 17, 2005
Interfacial inhibitors of protein-nucleic acid interactionsYves Pommier, Christophe Marchand
Nature Reviews. Drug Discovery|December 17, 2011
Interfacial inhibitors: targeting macromolecular complexesYves Pommier, Christophe Marchand
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2023
New Life of Topoisomerase I Inhibitors as Antibody-Drug Conjugate WarheadsYves Pommier, Anish Thomas
Experimental & Molecular Medicine|June 29, 2022
Structural, molecular, and functional insights into Schlafen proteinsUkhyun Jo, Yves Pommier
Cellular and Molecular Life Sciences : CMLS|January 23, 2014
The nuclear γ-H2AX apoptotic ring: implications for cancers and autoimmune diseasesStéphanie Solier, Yves Pommier
Pageof 63

Showing results (11-20 of 624) with videos related to

Sort By:
Pageof 63
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Targeting Topoisomerase I in the Era of Precision MedicineAnish Thomas, Yves Pommier
Science Translational Medicine|July 8, 2016
Small cell lung cancer: Time to revisit DNA-damaging chemotherapyAnish Thomas, Yves Pommier
Biochemistry|October 2, 2008
Mitochondrial topoisomerase I sites in the regulatory D-loop region of mitochondrial DNAHongliang Zhang, Yves Pommier
Cancer Research|April 14, 2023
BRCAness, Homologous Recombination Deficiencies, and Synthetic LethalityJunko Murai, Yves Pommier
Trends in Pharmacological Sciences|March 8, 2005
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discoveryYves Pommier, Jacqueline Cherfils
Current Medicinal Chemistry. Anti-Cancer Agents|August 17, 2005
Interfacial inhibitors of protein-nucleic acid interactionsYves Pommier, Christophe Marchand
Nature Reviews. Drug Discovery|December 17, 2011
Interfacial inhibitors: targeting macromolecular complexesYves Pommier, Christophe Marchand
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2023
New Life of Topoisomerase I Inhibitors as Antibody-Drug Conjugate WarheadsYves Pommier, Anish Thomas
Experimental & Molecular Medicine|June 29, 2022
Structural, molecular, and functional insights into Schlafen proteinsUkhyun Jo, Yves Pommier
Cellular and Molecular Life Sciences : CMLS|January 23, 2014
The nuclear γ-H2AX apoptotic ring: implications for cancers and autoimmune diseasesStéphanie Solier, Yves Pommier
Pageof 63